Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia

INTRODUCTION: This study investigates the cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes mellitus in Serbia. METHODS: A cost-utility analysis, implementing a simple short-term model, was used to compare treatment costs and outcomes wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalić, Nebojša, Russel-Szymczyk, Monika, Culic, Marina, Tikkanen, Christian Klyver, Chubb, Barrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984929/
https://www.ncbi.nlm.nih.gov/pubmed/29700772
http://dx.doi.org/10.1007/s13300-018-0426-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984929/
https://www.ncbi.nlm.nih.gov/pubmed/29700772
http://dx.doi.org/10.1007/s13300-018-0426-0

Ejemplares similares